首页> 外国专利> ANTIBODY-BASED MOLECULES SELECTIVE FOR THE {P}SER404 EPITOPE OF TAU AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF TAUOPATHY

ANTIBODY-BASED MOLECULES SELECTIVE FOR THE {P}SER404 EPITOPE OF TAU AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF TAUOPATHY

机译:Tau {P} SER404表位的基于抗体的分子及其在骨质疏松症诊断和治疗中的应用

摘要

The present invention relates to antibody-based molecules (including single domain antibody fragment, scFv molecules, antibodies, antibody fragments, diabodies, and the epitope-binding domains thereof) that are capable of immunospecifically and selectively binding to the {p}Ser404 Epitope of Tau. Such antibody-based molecules are useful to detect pathological Tau protein conformer if present in a biological sample, especially in conjunction with the diagnosis and/or treatment of Alzheimer's disease or other tauopathy, and thus provide a diagnostic for Alzheimer's disease and other Tau pathologies. The antibody -based molecules of the present invention have particular utility as diagnostic markers for, Alzheimer's disease and related tauopathies and as pharmaceutical compositions for the treatment of such conditions.
机译:本发明涉及基于抗体的分子(包括单结构域抗体片段,scFv分子,抗体,抗体片段,双抗体及其表位结合域),其能够免疫特异性地并选择性地结合至 Tau的Ser404表位。如果存在于生物样品中,则这种基于抗体的分子可用于检测病理性Tau蛋白构象异构体,特别是与阿尔茨海默氏病或​​其他tau蛋白病的诊断和/或治疗结合,从而提供对阿尔茨海默氏病和其他Tau病理学的诊断。本发明的基于抗体的分子具有特别的用途,作为阿尔茨海默氏病和相关疾病的诊断标志物,以及用于治疗此类疾病的药物组合物。

著录项

  • 公开/公告号WO2017027691A1

    专利类型

  • 公开/公告日2017-02-16

    原文格式PDF

  • 申请/专利权人 NEW YORK UNIVERSITY;

    申请/专利号WO2016US46520

  • 发明设计人 SIGURDSSON EINAR;

    申请日2016-08-11

  • 分类号C07K16/18;

  • 国家 WO

  • 入库时间 2022-08-21 13:32:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号